weight loss drug news today glp-1 september 2025 WHO adds weight-loss, diabetes drugs to essential medicines list | World Health Organization GLP-1 Agonists Market Report 2025-2033,
Description
A global survey asked healthcare providers which condition they are most eager to see GLP-1 medications approved for, and sleep apnea emerged as the top choice
What are the GLP-1 drugs in the market
GLP-1 receptor agonists and GLP-1/GIP combination therapies have become foundational treatments for type 2 diabetes and obesity
Zhang T, Cheng JK, Hu YM
What they did find, however, was people with obesity and alcohol use disorder reduced their drinking, on average, over the course of the 26-week study
